These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 29427615)

  • 1. Clinical Features of Ground Glass Opacity-Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor Size.
    Suzuki S; Sakurai H; Yotsukura M; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI
    Ann Thorac Surg; 2018 May; 105(5):1499-1506. PubMed ID: 29427615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the necessity of lymph node sampling in lung adenocarcinoma with ground glass opacities.
    Li H; Wu Y; Gao S; Zhou Y; Yang R; Wu Y
    Surgery; 2024 Sep; 176(3):927-933. PubMed ID: 38879379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity.
    Lu X; Chen Y; Li Y; Tang M; Zheng X
    Sci Rep; 2024 Jul; 14(1):15679. PubMed ID: 38977890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence Patterns and Patient Outcomes in Resected Lung Adenocarcinoma Differ according to Ground-Glass Opacity at CT.
    Park S; Lee SM; Choe J; Choi S; Do KH; Seo JB
    Radiology; 2023 May; 307(3):e222422. PubMed ID: 36943079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of surgical resection for radiologically subsolid T1N0 invasive lung adenocarcinoma: When is a wedge resection acceptable?
    Zhang C; Pan Y; Li H; Zhang Y; Li B; Zhang Y; Luo X; Miao L; Ma L; Chen S; Hu H; Sun Y; Zhang Y; Xiang J; Wang S; Gu Y; Li Y; Shen X; Wang Z; Ye T; Chen H
    J Thorac Cardiovasc Surg; 2024 Mar; 167(3):797-809.e2. PubMed ID: 37385528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmentectomy for ground glass-dominant invasive lung cancer with tumour diameter of 2-3 cm: protocol for a single-arm, multicentre, phase III trial (ECTOP1012).
    Chen S; Huang Q; Fu F; Wang Z; Zhang Y; Chen H
    BMJ Open; 2024 Jul; 14(7):e087088. PubMed ID: 38960464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a single-arm, multicenter, prospective, confirmatory phase III trial of wedge resection for invasive ground glass opacity-featured lung cancer with a size ≤2 cm and a consolidation tumor ratio between 0.25 and 0.5 (ECTOP-1020 study).
    Li T; Fu F; Zhang Y; Chen H
    J Thorac Dis; 2024 Jul; 16(7):4711-4718. PubMed ID: 39144343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of thoracoscopic monosubsegmentectomy for small ground-glass opacity dominant lung cancer.
    Yao F; Wang Z; Wu W; Zhu Q; Zhu Y; Chen L
    Eur J Surg Oncol; 2024 Apr; 50(4):108249. PubMed ID: 38479083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics.
    Goto E; Takamochi K; Kishikawa S; Hayashi T; Ueda T; Hattori A; Fukui M; Matsunaga T; Suzuki K;
    Lung Cancer; 2023 Oct; 184():107348. PubMed ID: 37619407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence Patterns and Patient Outcomes in Lung Adenocarcinoma Graded Clinical Stage II or Higher: Ground-Glass Opacity-Does It Matter?
    Qu R; Fu X
    Radiology; 2023 Aug; 308(2):e230754. PubMed ID: 37606574
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary: Through the looking glass: Is the consolidation/tumor ratio more important than size for clinical T1N0 lung cancer with a dominant ground-glass opacity?
    Lin J
    J Thorac Cardiovasc Surg; 2020 Jan; ():. PubMed ID: 32033817
    [No Abstract]   [Full Text] [Related]  

  • 12. A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.
    Toyooka S; Okumura N; Nakamura H; Nakata M; Yamashita M; Tada H; Kajiwara S; Watanabe N; Okada M; Sakamoto J; Aoe M; Soh J; Miyoshi S; Hotta K; Matsuo K; Date H
    J Thorac Oncol; 2018 May; 13(5):699-706. PubMed ID: 29505900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.
    Shewale JB; Nelson DB; Rice DC; Sepesi B; Hofstetter WL; Mehran RJ; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Antonoff MB
    Ann Thorac Surg; 2018 Jun; 105(6):1671-1677. PubMed ID: 29432718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
    Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
    Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
    Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
    Shajani-Yi Z; de Abreu FB; Peterson JD; Tsongalis GJ
    Neoplasia; 2018 Mar; 20(3):256-262. PubMed ID: 29454261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of COPD as Predictors of Lung Cancer.
    Carr LL; Jacobson S; Lynch DA; Foreman MG; Flenaugh EL; Hersh CP; Sciurba FC; Wilson DO; Sieren JC; Mulhall P; Kim V; Kinsey CM; Bowler RP
    Chest; 2018 Jun; 153(6):1326-1335. PubMed ID: 29452098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Sestak I; Buus R; Cuzick J; Dubsky P; Kronenwett R; Denkert C; Ferree S; Sgroi D; Schnabel C; Baehner FL; Mallon E; Dowsett M
    JAMA Oncol; 2018 Apr; 4(4):545-553. PubMed ID: 29450494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of T cell receptor repertoire in monozygotic twins concordant and discordant for chronic hepatitis B infection.
    Jiang Q; Liu Y; Xu B; Zheng W; Xiang X; Tang X; Dong H; Chen Y; Wang C; Deng G; Mao Q; Shang X; Wu Y
    Biochem Biophys Res Commun; 2018 Feb; 497(1):153-159. PubMed ID: 29438710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.